Sandra K. Johnston

1.7k total citations
42 papers, 1.1k citations indexed

About

Sandra K. Johnston is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra K. Johnston has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra K. Johnston's work include Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (12 papers) and Mathematical Biology Tumor Growth (7 papers). Sandra K. Johnston is often cited by papers focused on Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (12 papers) and Mathematical Biology Tumor Growth (7 papers). Sandra K. Johnston collaborates with scholars based in United States, South Africa and Ireland. Sandra K. Johnston's co-authors include Marc C. Chamberlain, Kristin R. Swanson, Andrea Hawkins‐Daarud, Maciej M. Mrugała, Russell C. Rockne, Cynthia M. Dougherty, Elaine A. Thompson, Peter Canoll, Anne Baldock and James P. Chandler and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sandra K. Johnston

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra K. Johnston United States	19	553	279	239	220	151	42	1.1k
Stefano Telera Italy	18	455 0.8×	212 0.8×	328 1.4×	217 1.0×	126 0.8×	55	1.1k
Ephraim W. Church United States	13	582 1.1×	259 0.9×	204 0.9×	337 1.5×	80 0.5×	39	1.1k
Fred H. Laningham United States	20	646 1.2×	314 1.1×	419 1.8×	134 0.6×	244 1.6×	40	1.4k
Jerome Graber United States	22	536 1.0×	278 1.0×	276 1.2×	161 0.7×	135 0.9×	71	1.4k
Mark ter Laan Netherlands	18	375 0.7×	240 0.9×	158 0.7×	121 0.6×	216 1.4×	50	1.3k
Arimantas Tamašauskas Lithuania	21	288 0.5×	248 0.9×	221 0.9×	203 0.9×	376 2.5×	96	1.3k
Scott D. Wait United States	21	293 0.5×	448 1.6×	300 1.3×	227 1.0×	120 0.8×	66	1.4k
Elizabeth Vera‐Bolanos United States	16	700 1.3×	148 0.5×	333 1.4×	197 0.9×	155 1.0×	24	993
Kathleen J. Helton United States	27	1.1k 2.0×	243 0.9×	285 1.2×	173 0.8×	240 1.6×	62	1.8k
Rasheed Zakaria United Kingdom	18	264 0.5×	155 0.6×	286 1.2×	150 0.7×	114 0.8×	67	943

Countries citing papers authored by Sandra K. Johnston

Since Specialization

Citations

This map shows the geographic impact of Sandra K. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra K. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra K. Johnston more than expected).

Fields of papers citing papers by Sandra K. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra K. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra K. Johnston. The network helps show where Sandra K. Johnston may publish in the future.

Co-authorship network of co-authors of Sandra K. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra K. Johnston. A scholar is included among the top collaborators of Sandra K. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra K. Johnston. Sandra K. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curatolo, Michele, Catherine P. Chia, Sandra K. Johnston, et al.. (2025). Multi-omics profiles of chronic low back pain and fibromyalgia—Study protocol. PLoS ONE. 20(4). e0312061–e0312061.

Cross, Nathan, Gang Luo, Nancy E. Lane, et al.. (2024). Subject-level spinal osteoporotic fracture prediction combining deep learning vertebral outputs and limited demographic data. Archives of Osteoporosis. 19(1). 87–87.

Luo, Gang, Nancy E. Lane, Li‐Yung Lui, et al.. (2023). Generalizability of Deep Learning Classification of Spinal Osteoporotic Compression Fractures on Radiographs Using an Adaptation of the Modified-2 Algorithm-Based Qualitative Criteria. Academic Radiology. 30(12). 2973–2987. 11 indexed citations

Luo, Gang, Nancy E. Lane, Li‐Yung Lui, et al.. (2022). Deep Learning Classification of Spinal Osteoporotic Compression Fractures on Radiographs using an Adaptation of the Genant Semiquantitative Criteria. Academic Radiology. 29(12). 1819–1832. 32 indexed citations

O’Reilly, Michael K., et al.. (2022). m2ABQ—a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures. Osteoporosis International. 34(1). 137–145. 1 indexed citations

Gold, Laura S., Zachary A. Marcum, Eric N. Meier, et al.. (2021). Patient, Provider, and Clinic Characteristics Associated with Opioid and Non-Opioid Pain Prescriptions for Patients Receiving Low Back Imaging in Primary Care. The Journal of the American Board of Family Medicine. 34(5). 950–963. 2 indexed citations

Singleton, Kyle, Alyx B. Porter, Leland Hu, et al.. (2020). Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies. Neuro-Oncology Advances. 2(1). vdaa085–vdaa085. 1 indexed citations

Gallaher, Jill, Andrea Hawkins‐Daarud, Russell C. Rockne, et al.. (2020). From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response. PLoS Computational Biology. 16(2). e1007672–e1007672. 29 indexed citations

Whitmire, Paula, Gina L. Mazza, Peter Canoll, et al.. (2020). Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care. Frontiers in Oncology. 10. 580750–580750. 13 indexed citations

10.

Whitmire, Paula, Sandra K. Johnston, Kyle Singleton, et al.. (2020). Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma. PLoS ONE. 15(3). e0230492–e0230492. 8 indexed citations

11.

Hawkins‐Daarud, Andrea, Sandra K. Johnston, & Kristin R. Swanson. (2019). Quantifying Uncertainty and Robustness in a Biomathematical Model–Based Patient-Specific Response Metric for Glioblastoma. JCO Clinical Cancer Informatics. 3(3). 1–8. 26 indexed citations

12.

Rockne, Russell C., Andrea Hawkins‐Daarud, Pamela Jackson, et al.. (2019). Improved model prediction of glioma growth utilizing tissue-specific boundary effects. Mathematical Biosciences. 312. 59–66. 15 indexed citations

13.

Baldock, Anne, Kevin Yagle, Donald E. Born, et al.. (2014). Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro-Oncology. 16(6). 779–786. 62 indexed citations

14.

Raizer, Jeffrey J., Sean Grimm, Alfred Rademaker, et al.. (2014). A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas. Journal of Neuro-Oncology. 117(1). 93–101. 83 indexed citations

15.

Chamberlain, Marc C. & Sandra K. Johnston. (2011). Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series. Journal of Neuro-Oncology. 104(3). 765–771. 55 indexed citations

16.

Chamberlain, Marc C. & Sandra K. Johnston. (2010). High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma. Neuro-Oncology. 12(7). 736–744. 70 indexed citations

17.

Chamberlain, Marc C. & Sandra K. Johnston. (2009). Salvage therapy with single agent bevacizumab for recurrent glioblastoma. Journal of Neuro-Oncology. 96(2). 259–269. 105 indexed citations

18.

Chamberlain, Marc C. & Sandra K. Johnston. (2009). Bevacizumab for recurrent alkylator‐refractory anaplastic oligodendroglioma. Cancer. 115(8). 1734–1743. 45 indexed citations

19.

Chamberlain, Marc C., Sandra K. Johnston, Alixis Van Horn, & Michael Glantz. (2008). Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C. Journal of Neuro-Oncology. 91(3). 271–277. 28 indexed citations

20.

Dougherty, Cynthia M., Sandra K. Johnston, & Elaine A. Thompson. (2007). Reliability and Validity of the Self-Efficacy Expectations and Outcome Expectations After Implantable Cardioverter Defibrillator Implantation Scales. Applied Nursing Research. 20(3). 116–124. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact